Innovating Works

H2020

Cerrada
HORIZON-CL5-2021-D6-01-12
Controlling infection on large passenger ships
ExpectedOutcome:Project outputs and results are expected to contribute to all of the following expected outcomes as applicable for the two sub-activities:
Sólo fondo perdido 0 €
Europeo
Esta convocatoria está cerrada Esta línea ya está cerrada por lo que no puedes aplicar. Cerró el pasado día 19-10-2021.
Se espera una próxima convocatoria para esta ayuda, aún no está clara la fecha exacta de inicio de convocatoria.
Por suerte, hemos conseguido la lista de proyectos financiados!
Presentación: Consorcio Consorcio: Esta ayuda está diseñada para aplicar a ella en formato consorcio..
Esta ayuda financia Proyectos:

ExpectedOutcome:Project outputs and results are expected to contribute to all of the following expected outcomes as applicable for the two sub-activities:

Communicable infections (Covid-19, influenza, norovirus) do not spread rapidly amongst passengers and crew on large passenger ships, in particular on cruise ships. The spread is controllable also beyond the vessel in ports and port communities.Communicable infections on board large passenger ships can be detected systematically at an early stage and effective measures are put in place to prevent the spread of infection. Crews and other personnel are duly trained.Large passenger ships are intrinsically designed to prevent the spread of infection and to facilitate measures in case of detection to eliminate further spread.An evidence base is established concerning the specific mechanisms facilitating the on-board spread of infection and the effectiveness of different mitigation methods. A knowledge base is publicly available concerning mechanisms facilitating the spread of on-board infection, mitigation measures and underlying evidence. Evidence based guidance for healthy passenger ship design is available to improve th... ver más

ExpectedOutcome:Project outputs and results are expected to contribute to all of the following expected outcomes as applicable for the two sub-activities:

Communicable infections (Covid-19, influenza, norovirus) do not spread rapidly amongst passengers and crew on large passenger ships, in particular on cruise ships. The spread is controllable also beyond the vessel in ports and port communities.Communicable infections on board large passenger ships can be detected systematically at an early stage and effective measures are put in place to prevent the spread of infection. Crews and other personnel are duly trained.Large passenger ships are intrinsically designed to prevent the spread of infection and to facilitate measures in case of detection to eliminate further spread.An evidence base is established concerning the specific mechanisms facilitating the on-board spread of infection and the effectiveness of different mitigation methods. A knowledge base is publicly available concerning mechanisms facilitating the spread of on-board infection, mitigation measures and underlying evidence. Evidence based guidance for healthy passenger ship design is available to improve the design of ships which can help avoiding infections and facilitate the detection on board infections at an early stage, inherently mitigate the spread of infection and facilitate actions to prevent its further spread.
Scope:Passenger ships and in particular cruise ships (with their high occupancy rates and elevated passenger and crew numbers of up to 8000 persons, close proximity of passengers and crews, high crew turnover with crews coming from many different countries, frequent port calls naturally implying common shore side excursions, and on-board activities with intense social interaction) have been implicated in the spread and multiplication of disease. Large and medium-sized cruise ships have seen a highly dynamic and sometimes dramatic multiplication of Covid-19 infections on-board and the disembarkation of several hundred infected (and often asymptomatic) passengers who subsequently became vectors for infection within the regions concerned and their home regions. In this context it needs to be kept in mind that cruise passengers often travel to and from the ship by air, adding to the potential spread. Passenger ships have also been hosts for the rapid spread of Norovirus illness, influenza and legionella infections. This can be particularly problematic for (generally smaller) passenger ships that undertake longer expedition-type cruises away from population centres, thus entirely or predominantly relying on on-board medical services and facilities. Europe as the world’s largest and almost exclusive producer of large and medium-sized passenger and cruise ships and as home to a large number of important cruise destinations must ensure a healthy on-board environment which is also crucial for the viability and the sustainable growth of the business. Whilst guidelines to control the spread of on-board infections have been published, it is clear that these are not fully effective and there is a lack of an evidence base to underpin the effectiveness of the suggested measures for different infections. Important knowledge gaps continue to exist and so far the real effectiveness of different mitigation measures now deployed remains largely anecdotal.

To address these challenges, proposals will address one of the following two aspects and cover all of the tasks mentioned.

“Infection control on-board large passenger ships - prevention, mitigation and management”. Establishing a comprehensive scientific basis concerning the effectiveness of different prevention, mitigation and management measures. Developing and demonstrating solutions for improving the prevention, mitigation and management of on-board disease and illness. Cooperate and coordinate with other projects selected from this topic as well as other relevant actions such as the EU’s “healthy gateways” action. Outcomes and data to be made publicly available to facilitate the take up of best practices, also in function of vessel type and size, type of cruise and cruise destination. A distinction should be made between large ferries as typically deployed in Europe and cruise ships. “Healthy ship design”: Applying a bottom-up evidence based approach address the functional and concept design of large passenger ships so as to reduce the on-board spread of infection. Research should in particular address ventilation systems and their airflows, germicidal surfaces and disinfection practices, contamination control in all relevant ship areas, facilitating enhanced quarantine, process separation, the design of social areas including those for the crew, the design of crew work areas, especially pantries, laundries etc.. In this respect a better interaction of people with the vessel and its equipment on the basis of social innovations (e.g. hands-free accessibility solutions) should also be considered.Innovative systems should be addressed to enable early stage detection of the spread of on-board infections such as for example employing AI, big data, smart sensors etc. Cooperate and coordinate with other projects selected from this topic as well as other relevant actions such as the EU’s “healthy gateways” action. Outcomes and guidance concerning healthy ship design should be made available to facilitate the take up of best practices by ship interior designers, shipyards, and equipment manufacturers. This topic requires the effective contribution of SSH disciplines and the involvement of SSH experts, institutions as well as the inclusion of relevant SSH expertise, in order to produce meaningful and significant effects enhancing the societal impact of the related research activities.


Specific Topic Conditions:Activities are expected to achieve TRL 5 by the end of the project – see General Annex B.




Cross-cutting Priorities:Socio-economic science and humanitiesSocial InnovationOcean sustainability and blue economy


ver menos

Temáticas Obligatorias del proyecto: Temática principal:

Características del consorcio

Ámbito Europeo : La ayuda es de ámbito europeo, puede aplicar a esta linea cualquier empresa que forme parte de la Comunidad Europea.
Tipo y tamaño de organizaciones: El diseño de consorcio necesario para la tramitación de esta ayuda necesita de:
Empresas Micro, Pequeña, Mediana, Grande
Centros Tecnológicos
Universidades
Organismos públicos

Características del Proyecto

Requisitos de diseño: Duración: Requisitos técnicos: ExpectedOutcome:Project outputs and results are expected to contribute to all of the following expected outcomes as applicable for the two sub-activities: ¿Quieres ejemplos? Puedes consultar aquí los últimos proyectos conocidos financiados por esta línea, sus tecnologías, sus presupuestos y sus compañías.
Capítulos financiables: Los capítulos de gastos financiables para esta línea son:
Madurez tecnológica: La tramitación de esta ayuda requiere de un nivel tecnológico mínimo en el proyecto de TRL 4:. Es el primer paso para determinar si los componentes individuales funcionarán juntos como un sistema en un entorno de laboratorio. Es un sistema de baja fidelidad para demostrar la funcionalidad básica y se definen las predicciones de rendimiento asociadas en relación con el entorno operativo final. leer más.
TRL esperado:

Características de la financiación

Intensidad de la ayuda: Sólo fondo perdido + info
Fondo perdido:
0% 25% 50% 75% 100%
The funding rate for RIA projects is 100 % of the eligible costs for all types of organizations.
Condiciones: No existe condiciones financieras para el beneficiario.

Información adicional de la convocatoria

Efecto incentivador: Esta ayuda no tiene efecto incentivador. + info.
Respuesta Organismo: Se calcula que aproximadamente, la respuesta del organismo una vez tramitada la ayuda es de:
Meses de respuesta:
Muy Competitiva:
No Competitiva Competitiva Muy Competitiva
No conocemos el presupuesto total de la línea pero en los últimos 6 meses la línea ha concecido
Total concedido en los últimos 6 meses.
Minimis: Esta línea de financiación NO considera una “ayuda de minimis”. Puedes consultar la normativa aquí.

Otras ventajas

Sello PYME: Tramitar esta ayuda con éxito permite conseguir el sello de calidad de “sello pyme innovadora”. Que permite ciertas ventajas fiscales.